Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
or

Nasdaq Pharmaceuticals ETF (FTXH)

Nasdaq Pharmaceuticals ETF (FTXH)
10.98 x 2 43.61 x 1
Pre-market by (Cboe BZX)
27.53 -0.19 (-0.69%) 03/26/25 [NASDAQ]
10.98 x 2 43.61 x 1
Pre-market 27.53 unch (unch) 16:15 ET
Quote Overview for Wed, Mar 26th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
27.47
Day High
27.70
Open 27.70
Previous Close 27.72 27.72
Volume 1,200 1,200
Avg Vol 1,740 1,740
Stochastic %K 17.19% 17.19%
Weighted Alpha -1.90 -1.90
5-Day Change -0.83 (-2.93%) -0.83 (-2.93%)
52-Week Range 25.73 - 29.72 25.73 - 29.72
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Fund Family First Trust Portfolios
  • Assets Under Management 13,765,000
  • Shares Outstanding, K 500
  • 60-Month Beta 0.70
  • Price/Earnings ttm 16.59
  • Annual Dividend & Yield 0.45 (1.63%)
  • Most Recent Dividend 0.130 on 12/13/24
  • Management Fee 0.60%
  • INDUSTRY GROUPING:

    ETFs - Large Cap

Price Performance

See More
Period Period Low Period High Performance
1-Month
27.47 +0.22%
on 03/26/25
Period Open: 28.06
28.94 -4.87%
on 03/10/25
-0.53 (-1.89%)
since 02/26/25
3-Month
26.82 +2.65%
on 12/30/24
Period Open: 27.39
28.94 -4.87%
on 03/10/25
+0.14 (+0.51%)
since 12/26/24
52-Week
25.73 +7.00%
on 04/19/24
Period Open: 27.60
29.72 -7.37%
on 08/29/24
-0.07 (-0.24%)
since 03/26/24

Most Recent Stories

More News
What Are Wall Street Analysts' Target Price for Bristol-Myers Squibb Stock?

Pharma giant Bristol-Myers Squibb has notably outpaced the broader pharma industry over the past year and analysts remain moderately bullish on the stock’s prospects.

$SPX : 5,712.20 (-1.12%)
BMY : 59.21 (+0.03%)
FTXH : 27.53 (-0.69%)
ETFs in Focus Post JNJ Q3 Earnings Beat, Target Price Hike

Johnson & Johnson JNJ infused positive optimism for the broader healthcare sector after posting solid third-quarter 2024 earnings on Oct. 15. The world's biggest healthcare products maker continued with...

XLV : 144.74 (-0.36%)
JNJ : 161.72 (+0.43%)
IHE : 68.76 (-1.18%)
IYH : 60.49 (-0.56%)
PPH : 90.32 (-0.73%)
FTXH : 27.53 (-0.69%)
Do Wall Street Analysts Like Gilead Sciences Stock?

Gilead Sciences has underperformed the broader market over the past year, yet Wall Street analysts remain moderately bullish about the stock’s prospects.

GILD : 109.27 (+1.28%)
$SPX : 5,712.20 (-1.12%)
FTXH : 27.53 (-0.69%)
Bristol-Myers Squibb Stock: Analyst Estimates & Ratings

Bristol-Myers Squibb has underperformed the market over the past year, and Wall Street analysts remain cautious about the stock prospects.

BMY : 59.21 (+0.03%)
$SPX : 5,712.20 (-1.12%)
FTXH : 27.53 (-0.69%)
MS : 122.20 (-2.40%)
First Trust Advisors L.P. Announces Distributions for Exchange-Traded Funds

First Trust Advisors L.P. ("FTA") announces the declaration of distributions for 138 exchange-traded fund(s) (each a “Fund,” collectively, the “Funds”) advised by FTA.

FCAL : 48.79 (-0.51%)
FEMB : 27.07 (-0.40%)
FMB : 50.44 (-0.51%)
FMHI : 47.85 (-0.44%)
RFDI : 67.50 (-0.94%)
RFEM : 66.16 (-0.82%)
RFEU : 64.67 (-1.54%)
FTSL : 46.01 (-0.11%)
FTSM : 59.99 (-0.01%)
HISF : 44.30 (-0.20%)
HYLS : 41.21 (-0.41%)
LMBS : 49.17 (-0.06%)
First Trust Advisors L.P. Announces Distributions for Exchange-Traded Funds

First Trust Advisors L.P. ("FTA") announces the declaration of distributions for 129 exchange-traded fund(s) (each a “Fund,” collectively, the “Funds”) advised by FTA.

FCAL : 48.79 (-0.51%)
FEMB : 27.07 (-0.40%)
FMB : 50.44 (-0.51%)
FMHI : 47.85 (-0.44%)
RFDI : 67.50 (-0.94%)
RFEM : 66.16 (-0.82%)
RFEU : 64.67 (-1.54%)
FCVT : 35.74 (-1.43%)
FTSL : 46.01 (-0.11%)
HISF : 44.30 (-0.20%)
HYLS : 41.21 (-0.41%)
LMBS : 49.17 (-0.06%)
First Trust Advisors L.P. Announces Distributions for Exchange-Traded Funds

First Trust Advisors L.P. ("FTA") announces the declaration of distributions for 135 exchange-traded fund(s) (each a “Fund,” collectively, the “Funds”) advised by FTA.

FCAL : 48.79 (-0.51%)
FEMB : 27.07 (-0.40%)
FMB : 50.44 (-0.51%)
FMHI : 47.85 (-0.44%)
RFDI : 67.50 (-0.94%)
RFEM : 66.16 (-0.82%)
RFEU : 64.67 (-1.54%)
FCVT : 35.74 (-1.43%)
FTSL : 46.01 (-0.11%)
HISF : 44.30 (-0.20%)
HYLS : 41.21 (-0.41%)
LMBS : 49.17 (-0.06%)
First Trust Advisors L.P. Announces Distributions for Exchange-Traded Funds

First Trust Advisors L.P. ("FTA") announces the declaration of distributions for 120 exchange-traded fund(s) (each a “Fund,” collectively, the “Funds”) advised by FTA.

FCAL : 48.79 (-0.51%)
FEMB : 27.07 (-0.40%)
FMB : 50.44 (-0.51%)
FMHI : 47.85 (-0.44%)
RFDI : 67.50 (-0.94%)
RFEU : 64.67 (-1.54%)
FCVT : 35.74 (-1.43%)
FTSL : 46.01 (-0.11%)
HISF : 44.30 (-0.20%)
HYLS : 41.21 (-0.41%)
LMBS : 49.17 (-0.06%)
FTHI : 22.35 (-0.97%)
First Trust Advisors L.P. Announces Distributions for Exchange-Traded Funds

First Trust Advisors L.P. ("FTA") announces the declaration of distributions for 133 exchange-traded fund(s) (each a “Fund,” collectively, the “Funds”) advised by FTA.

FCAL : 48.79 (-0.51%)
FEMB : 27.07 (-0.40%)
FMB : 50.44 (-0.51%)
FMHI : 47.85 (-0.44%)
RFDI : 67.50 (-0.94%)
RFEM : 66.16 (-0.82%)
RFEU : 64.67 (-1.54%)
FCVT : 35.74 (-1.43%)
FDIV : 27.12 (+0.97%)
FTSL : 46.01 (-0.11%)
FTSM : 59.99 (-0.01%)
HYLS : 41.21 (-0.41%)
First Trust Advisors L.P. Announces Distributions for Exchange-Traded Funds

First Trust Advisors L.P. ("FTA") announces the declaration of distributions for 122 exchange-traded fund(s) (each a “Fund,” collectively, the “Funds”) advised by FTA.

FCAL : 48.79 (-0.51%)
FEMB : 27.07 (-0.40%)
FMB : 50.44 (-0.51%)
FMHI : 47.85 (-0.44%)
RFDI : 67.50 (-0.94%)
RFEM : 66.16 (-0.82%)
RFEU : 64.67 (-1.54%)
FCVT : 35.74 (-1.43%)
FDIV : 27.12 (+0.97%)
FTSL : 46.01 (-0.11%)
HYLS : 41.21 (-0.41%)
LMBS : 49.17 (-0.06%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 32% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Fund Summary

The First Trust Nasdaq Pharmaceuticals ETF is an exchange-traded fund. The investment objective of the Fund is to seek investment results that correspond generally to the price and yield, before the Fund's fees and expenses, of an index called the Nasdaq US Smart Pharmaceuticals Index. The Fund seeks...

See More

Top 10 Holdings

Key Turning Points

3rd Resistance Point 27.89
2nd Resistance Point 27.80
1st Resistance Point 27.66
Last Price 27.53
1st Support Level 27.43
2nd Support Level 27.34
3rd Support Level 27.20

See More

52-Week High 29.72
Fibonacci 61.8% 28.20
Fibonacci 50% 27.72
Last Price 27.53
Fibonacci 38.2% 27.25
52-Week Low 25.73

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Trading Volatility: How to Use IV Rank & Percentile for Smarter Options Strategies